NASDAQ

Entrada Therapeutics, Inc. (TRDA)

♥ 552 Thanks from members

Live price chart, market sentiment, and community perspectives for Entrada Therapeutics, Inc. (NASDAQ: TRDA).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Dmitri NussbaumFounder: Matthew FosterLeadership: Martin Williams (CEO)Leadership: Paula Jacobs (CFO)Holder: RA Capital ManagementHolder: Fidelity Management and ResearchHolder: Wellington ManagementEEV PlatformENTR-601-44Neuromuscular Therapeutics#TRDA#Entrada Therapeutics#Biotech#Endosomal Escape#NASDAQ Stock